# Xenon Therapy for Children With Autism Spectrum Disorder

> **NCT07435103** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **The Children's Hospital of Zhejiang University School of Medicine** · enrollment: 72 (estimated)

## Conditions studied

- Autism Spectrum Disorder (ASD)
- Autism

## Interventions

- **DRUG:** Xenon

## Key facts

- **NCT ID:** NCT07435103
- **Lead sponsor:** The Children's Hospital of Zhejiang University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2027-03-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2026-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07435103

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07435103, "Xenon Therapy for Children With Autism Spectrum Disorder". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07435103. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*